Search results for "Miscarriage"

showing 10 items of 51 documents

Female obesity impairs in vitro fertilization outcome without affecting embryo quality.

2008

Objective To compare embryo quality and reproductive outcome in our IVF program according to the women's body mass index (BMI). Design Retrospective study. Setting University-affiliated infertility clinic, between January 2001 and April 2007. Patient(s) Women undergoing a total of 6,500 IVF–intracytoplasmic sperm injection (ICSI) cycles. Intervention(s) Six thousand five hundred IVF-ICSI cycles were included and divided into four groups: lean ( 2 ; n=1,070; 16.5%); normal (20–24.9 kg/m 2 ; n=3,930; 60.5%); overweight (25–29.9 kg/m 2 ; n=1,081; 16.6%); and obese (≥30 kg/m 2 ; n=419; 6.4%). Main Outcome Measure(s) Comparison of embryo quality and reproductive outcome (implantation, pregnancy,…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentFertilization in VitroMiscarriageBody Mass IndexOvulation InductionThinnessPregnancymedicineHumansObesitySperm Injections IntracytoplasmicMetaphaseRetrospective StudiesGynecologyPregnancyIn vitro fertilisationObstetricsbusiness.industryBody WeightSmokingObstetrics and GynecologyOverweightmedicine.diseaseAbortion SpontaneousPregnancy rateTreatment OutcomeReproductive MedicineFertilizationembryonic structuresOocytesGestationFemalebusinessLive birthBody mass indexEmbryo qualityFertility and sterility
researchProduct

GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controll…

2009

Objective To assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles. Design Single-center, randomized, single-blind, placebo-controlled trial. Setting University-affiliated infertility clinic, between February 2005 and December 2007. Patient(s) Three hundred forty-four women undergoing IUI owing to mild to moderate male factor or donor sperm indication. Intervention(s) Random administration to either a single subcutaneous injection of 0.1 mg triptorelin (group A; n = 172) 8 days after hCG administration, or solvent only (group B; n=172) at the same time. Main Outcome Measure(s) Pregnancy rate was the primary outcom…

AdultMalemedicine.medical_specialtyTime FactorsPregnancy Ratemedicine.medical_treatmentLuteal phaseDrug Administration Schedulelaw.inventionMiscarriageGonadotropin-Releasing HormonePlacebosRandomized controlled triallawPregnancyMedicineHumansSingle-Blind MethodEmbryo ImplantationInsemination ArtificialGynecologyPregnancyTriptorelin Pamoatebusiness.industryObstetricsArtificial inseminationUterusPregnancy OutcomeObstetrics and GynecologyFertility Agents Femalemedicine.diseaseTriptorelinPregnancy rateReproductive MedicineGestationFemalebusinessAlgorithmsmedicine.drugFertility and sterility
researchProduct

Risk of infection and adverse outcomes among pregnant working women in selected occupational groups: A study in the Danish National Birth Cohort

2010

Abstract Background Exposure to infectious pathogens is a frequent occupational hazard for women who work with patients, children, animals or animal products. The purpose of the present study is to investigate if women working in occupations where exposure to infections agents is common have a high risk of infections and adverse pregnancy outcomes. Methods We used data from the Danish National Birth Cohort, a population-based cohort study and studied the risk of Infection and adverse outcomes in pregnant women working with patients, with children, with food products or with animals. The regression analysis were adjusted for the following covariates: maternal age, parity, history of miscarri…

AdultPediatricsmedicine.medical_specialtyDenmarkHealth PersonnelHealth Toxicology and MutagenesisPopulationCongenital AbnormalitiesMiscarriageCohort Studieslcsh:RC963-969PregnancyRisk FactorsOccupational ExposuremedicineFood IndustryHumansChild CarePregnancy Complications InfectiousChildeducationeducation.field_of_studyPregnancybusiness.industryTeachingResearchlcsh:Public aspects of medicineInfant NewbornPregnancy OutcomeAbsolute risk reductionPublic Health Environmental and Occupational Healthlcsh:RA1-1270medicine.diseaseOccupational DiseasesSick leaveWorkforcelcsh:Industrial medicine. Industrial hygieneSmall for gestational ageFemalePregnant WomenbusinessBody mass indexCohort studyDemographyEnvironmental Health
researchProduct

Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial.

2013

Objective To evaluate the influence of 10 minutes of bed rest after ET on the achievement of a live-born infant (LBI) in patients undergoing IVF treatment with oocyte donation (OD). Design Prospective, randomized, parallel assignment, controlled trial. Setting Private IVF center. Patient(s) A total of 240 patients undergoing a first IVF cycle with OD in our center. Intervention(s) Ten minutes of bed rest after ET or no bed rest, that is, allowing patients to ambulate immediately after the ET. Main Outcome Measure(s) The primary outcome was LBI rate per randomized patient. Secondary outcomes were implantation rate and biochemical and clinical miscarriage rates. Result(s) LBI rates (56.7% vs.…

Adultmedicine.medical_specialtyAdolescentPregnancy Ratemedicine.medical_treatmentFertilization in VitroBed restMiscarriagelaw.inventionYoung AdultRandomized controlled triallawPregnancyStatistical significancemedicineHumansEmbryo ImplantationPostoperative PeriodGynecologybusiness.industryInfant NewbornObstetrics and GynecologyMiddle Agedmedicine.diseaseEmbryo TransferEmbryo transferClinical trialPregnancy rateReproductive MedicineAnesthesiaInfertilityApgar scoreFemalebusinessAlgorithmsBed RestFertility and sterility
researchProduct

Improved accuracy of hysteroembryoscopic biopsies for karyotyping early missed abortions

2003

Abstract Objective To assess the potential of direct embryo and chorion biopsies obtained by hysteroembryoscopy for karyotyping early missed abortions. Design Clinical prospective descriptive study. Setting Instituto Valenciano de Infertilidad, Valencia, Spain. Patient(s) Sixty-eight women (71 gestational sacs) with missed abortions. The gestational age on ultrasound was 6.3 weeks (range, 4–10 weeks). Intervention(s) Transcervical hysteroembryoscopy before curettage. Main outcome measure(s) Comparison between the cytogenetic results from hysteroembryoscopic biospies and those of the curettage material. Result(s) Hysteroembryoscopic biopsies could be taken in 97.2% of the gestational sacs. D…

Adultmedicine.medical_specialtyBiopsyPlacentamedicine.medical_treatmentGestational sacHysteroscopyAbortionCurettageMiscarriageBiopsyTwins DizygoticHumansMedicineProspective StudiesDiagnostic ErrorsGynecologymedicine.diagnostic_testMosaicismbusiness.industryObstetricsFetoscopyObstetrics and GynecologyGestational ageChorionMiddle AgedEmbryo Mammalianmedicine.diseaseCurettagemedicine.anatomical_structureReproductive MedicineHysteroscopyKaryotypingCytogenetic Analysisembryonic structuresGestationFemaleAbortion MissedbusinessFertility and Sterility
researchProduct

Preimplantation genetic diagnosis by fluorescence in situ hybridization: clinical possibilities and pitfalls.

2003

Preimplantation genetic diagnosis using the fluorescence in situ hybridization technique (FISH) is being used widely to prevent the transmission of sex-linked diseases, to screen for translocations, and for aneuploidy screenng in specific invitro fertilization (IVF) patient groups, along with FISH analysis of spematozoa in intertile men. In this study, we aim to critically analyze our clinical results in patients at risk of transmitting sex-linked diseases (n = 55), in carriers of translocations (n = 43), in women who have recurent miscarriage (two or more miscarriages) (n = 128), recurrent IVF failure (three or more failed IVF attempts) (n = 47), and patients of advanced maternal age (37 y…

Adultmedicine.medical_specialtyGenetic LinkagePregnancy High-RiskAneuploidyFertilization in VitroBiologyPreimplantation genetic diagnosisTranslocation GeneticMiscarriageRecurrent miscarriagemedicineHumansAdvanced maternal ageTreatment FailureIn Situ Hybridization FluorescencePreimplantation DiagnosisGynecologyPregnancySex Chromosomesmedicine.diagnostic_testIncidence (epidemiology)Genetic Diseases InbornObstetrics and Gynecologymedicine.diseaseAbortion SpontaneousFemaleFluorescence in situ hybridizationMaternal AgeJournal of the Society for Gynecologic Investigation
researchProduct

Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment.

2007

Objective To evaluate and compare the risk of early pregnancy loss in patients stimulated with GnRH antagonist protocols according to oral contraceptive pill (OCP) pretreatment. Design Retrospective case–control study. Setting Instituto Valenciano de Infertilidad. University of Valencia. Spain. Patient(s) One thousand five hundred thirty-nine patients, aged Intervention(s) Reproductive outcome was compared based on the application (or not) of OCP pretreatment: 944 women were included in the OCP group and 595 in the non-OCP group. The Student's t test was used for statistics. Main Outcome Measure(s) Pregnancy, biochemical pregnancy, ectopic pregnancy, early clinical pregnancy loss, early pre…

Adultmedicine.medical_specialtyOral contraceptive pillPregnancy Ratemedicine.drug_classEarly Pregnancy LossGonadotropin-releasing hormone antagonistMiscarriageGonadotropin-Releasing HormonePregnancymedicineHumansRetrospective StudiesGynecologyPregnancyEctopic pregnancybusiness.industryObstetrics and Gynecologymedicine.diseasePregnancy rateReproductive MedicinePillCase-Control StudiesEmbryo LossFemalebusinessContraceptives OralFertility and sterility
researchProduct

Age and Uterine Receptiveness: Predicting the Outcome of Oocyte Donation Cycles

2005

The impact of advancing age on uterine receptiveness has always been a concern of the medical establishment. Oocyte donation (OD) is the perfect model for ascertaining the extent of this relationship, but the literature is somewhat unreliable, mainly due to the limited samples on which the studies are based and insufficient control of important variables such as embryo quality.The present work was developed in a private infertility clinic.We retrospectively evaluate the results of 3089 OD cycles that ended up in a d 3 embryo transfer. Severe male factor infertility was an exclusion criterion.The impact of patients' age on pregnancy, implantation, and miscarriage rates and obstetric outcome …

Adultmedicine.medical_specialtyPregnancy RateEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)AbortionBiochemistryMiscarriageEndocrinologyPregnancyInternal medicineHumansMedicineEmbryo ImplantationRetrospective StudiesGynecologyPregnancyOocyte Donationbusiness.industryBiochemistry (medical)Retrospective cohort studyMiddle Agedmedicine.diseaseEmbryo transferAbortion SpontaneousPregnancy rateEndocrinologyMultivariate AnalysisFemalebusinessEmbryo qualityMaternal AgeThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors

2013

Objective To analyze the reproductive outcome of recipients of donated ova according to their body mass index (BMI). Design Twelve-year retrospective cohort analysis. Setting Fertility clinics. Patient(s) 9,587 first cycles of ovum donation with ova from normoweight donors. Intervention(s) Recipients divided according to their BMI to analyze IVF laboratory and outcome parameters: lean with BMI 2 (n = 1,458; 15.2%); normoweight with BMI 20–24.9 kg/m 2 (n = 5,706; 59.5%), overweight with BMI 25–29.9 kg/m 2 (n = 1,770; 18.5%), and obese with BMI ≥30 kg/m 2 (n = 653; 6.8%). Main Outcome Measure(s) Implantation, biochemical and clinical pregnancy, miscarriage, and live-birth rates. Result(s) In …

Adultmedicine.medical_specialtyPregnancy RateFertilization in VitroOverweightBody Mass IndexMiscarriagePregnancyRisk FactorsOdds RatioHumansMedicineEmbryo ImplantationObesityTwin PregnancyRetrospective StudiesGynecologyAnalysis of VariancePregnancyChi-Square DistributionOocyte Donationbusiness.industryObstetricsBody WeightUterusnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseaseObesityTissue DonorsAbortion SpontaneousPregnancy rateLogistic ModelsTreatment OutcomeReproductive MedicineSpainPregnancy TwinFemalemedicine.symptomLive birthbusinessInfertility FemaleLive BirthBody mass indexFertility and Sterility
researchProduct

Oocyte donation outcome after oncological treatment in cancer survivors.

2012

Objective To study reproductive outcome in patients cured of cancer who required oocyte donation (OD) owing to iatrogenic ovarian dysfunction. Design Multicenter, unmatched, retrospective cohorts study. Setting Private, university-affiliated group of clinics. Patient(s) Women treated and cured of cancer (n = 142) who underwent 333 cycles of OD (exposed group) and women without a previous cancer diagnosis (n = 17,844) who underwent 29,778 cycles of OD (unexposed cohort) between January 2000 and January 2012. Intervention(s) Retrospective chart review. Main Outcome Measure(s) Pregnancy, implantation, miscarriage, and ongoing pregnancy rates. Result(s) There were no differences in terms of pre…

Adultmedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentMiscarriageCohort StudiesPregnancyRisk FactorsNeoplasmsmedicineHumansOvarian DiseasesSurvivorsRetrospective StudiesGynecologyPregnancyChemotherapyOocyte Donationbusiness.industryIncidenceCancer typePregnancy OutcomeObstetrics and GynecologyCancermedicine.diseaseRadiation therapyAbortion SpontaneousCausalityTreatment OutcomeReproductive MedicineSpainOocyte donationOvarian dysfunctionFemalebusinessInfertility FemaleFertility and sterility
researchProduct